Food Supply Security Rebrands as QuantiPath

The biotech company is preparing for the commercial launch of its flagship product, GenoPATHx, a pathogen testing kit that identifies and quantifies Salmonella serovars.

QuantiPath.bio

Courtesy QuantiPath.bio

DENVER — Food Supply Security announced it has rebranded as QuantiPath.bio, ushering in a new era for the biotech company as it prepares for the commercial launch of its flagship product, GenoPATHx — a next-generation pathogen testing kit that identifies and quantifies Salmonella serovars.

The transformation to QuantiPath.bio comes with a vibrant new visual identity and brand strategy designed to reflect the scientific rigor and forward-thinking energy of the company, said QuantiPath. The updated name, logo and iconography emphasize the DNA-level precision and security the company provides to the food industry.

The new brand also introduces a color spectrum that draws from molecular marker patterns uncovered through QuantiPath's proprietary testing method, which distinguishes not just which serovars are present in a sample, but how much, a capability not commonly available in traditional pathogen detection solutions, according to the company. This quantification capability is a cornerstone of the company's product promise, said QuantiPath, reflected in its new brand headline: Revolutionary Salmonella Serovar Identification & Quantification.

"Biotech brands can — and should — be equal parts vision and science," said Janine Williams, chief marketing officer. "When tackling something as important as the future of food safety, we must stand out with a clear voice and a recognizable brand. Our focus is on developing a product vision that earns that trust, demonstrates our innovation and supports the company's long-term growth."

QuantiPath President and CEO John LoPorto said he believes this brand evolution and expansion of its executive ranks is essential as the company experiences increasing attention from major players in the food production and regulatory sectors.

"We're seeing growing demand for our solution because of its unprecedented specificity, quantification and speed," said LoPorto. "But just as important as the innovation is the credibility and consistency we present to the public, our partners and our investors. This rebrand captures the integrity of our science and the future-forward mindset of our leadership. Our ability to bridge the gap between hard science and strong brand presence is key as we scale." 

As part of the rebrand rollout, QuantiPath will also launch an ecommerce platform and industry blog in the coming weeks to support engagement and education leading up to the commercial release of GenoPATHx.